This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Malignant Pleural Effusion Market

Market Insights on Malignant Pleural Effusion covering sales outlook, demand forecast & up-to-date key trends

Malignant Pleural Effusion Market by Treatment, Diagnosis, End-Users & Region – Forecast 2023–2033

Malignant Pleural Effusion Market Snapshot (2023-2033)

The global malignant pleural effusion market is expected to garner a market value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by registering a CAGR of 6% in the forecast period 2023-2033. The increasing incidence of pleural effusion disease and rising awareness of advancement in pleural effusions treatment with different types of techniques in the current market works as a driver for the market. The market for Malignant Pleural Effusion registered a CAGR of 4% in the historical period 2018-2022.

Clinical examinations and procedures are carried out to diagnose the condition, which aids medical professionals in making additional decisions about medicine, testing, and recuperation and is expected to accelerate market expansion throughout the projection period. Recent epidemiological data from WHO suggests that approximately more than one million pleural effusions are diagnosed in the United States each year.

Report Attribute

Details

Expected Market Value (2023)

US$ 4.5 Billion

Anticipated Forecast Value (2033)

US$ 8.06 Billion

Projected Growth Rate (2023-2033)

6% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

2018-2022 Malignant Pleural Effusion Market Demand Analysis vs. Forecast 2023-2033

According to market research and competitive intelligence provider Future Market Insights- the market for Malignant Pleural Effusion reflected a value of 4% during the historical period, 2018-2022. Various factors such as awareness in wellness and health, the diagnostics, and pathology segment are improving in the developing countries nowadays which grows the therapeutics market. The research and development activities in the field like emerging novel therapeutics, increasing the efficacy of medicine as well as treatment.

Selling campaigns initiated by the global players is growing the market progressively. Increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of pleural effusions is fuelling the market growth. Thus, the market for Malignant Pleural Effusion is expected to register a CAGR of 6% in the forecast period 2023-2033.

Which are Some Prominent Drivers of the Malignant Pleural Effusion Market?

Increasing Incidence of Malignant Pleural Effusion disease post covid-19 pandemic to push the market growth

The increasing prevalence of Malignant Pleural Effusion disease is one of the biggest drivers of the market. After The covid-19 pandemic hit the world, various research was conducted to find a correlation between Covid-19 infection and pleural effusion.

For instance, the article “Prevalence and Clinical Outcomes of Pleural Effusion in Covid-19 Patients: A Systematic Review and Meta-Analysis” published in January 2022 showed that pleural effusion is related to the risk and prognosis of Covid-19 disease.

Pleural effusion can be used as a prognostic indicator to assess the likelihood of poorer outcomes in Covid-19 patients; as a result, the researchers of the above-mentioned research article advised that hospitalized Covid-19 patients with pleural effusion be handled promptly. Considering these in depth studies, the pandemic showed a considerable impact on the market studied.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Challenges Faced by the Malignant Pleural Effusion Market?

Expensive Cost of Treatment to restrict Market Growth

The expensive treatment of Malignant Pleural Effusion, less awareness of Malignant Pleural Effusion disease, and insubstantial treatment options are hampering the market growth.

Region-Wise Insights

How is the Market for Malignant Pleural Effusion Turning Out in the Asia Pacific Region?

Improvement in healthcare spending propelling growth of Malignant Pleural Effusion in Asia Pacific

The Asia Pacific is expected to exhibit the fastest growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period. The growth is owed to increased awareness, significant increases in healthcare spending, and a rising frequency of malignant pleural effusion in the region.

Asia Pacific is an emerging market due to the increase in point of care approach to health & care. Increasing number of hospitals in India and China makes a promising market for Pleural effusions treatment market worldwide.

What are the Factors Boosting the Market for Malignant Pleural Effusion in North America?

High Prevalence of various diseases shaping landscape for Malignant Pleural Effusion in North America

North America is anticipated to acquire a market share of about 45% in the forecast period. This growth is attributable to the rising prevalence of pleural effusions in the region. An article published by WebMD LLC in October 2021 stated that approximately 1.5 million pleural effusions are diagnosed in the United States every year and in industrialized countries, the estimated prevalence of pleural effusion is 320 cases per 100,000 people.

This ever widening burden of the condition on the healthcare facilities is creating demand for the treatment globally, expected to fuel the market growth during the analysis period. Furthermore, the rising geriatric population is leading to an increase in the prevalence of various diseases, growing the health and economic burden.

As per the American Heart Association data updated in April 2022, nearly 115 million people have hypertension, 100 million have obesity, 92 million have prediabetes, 26 million have diabetes, and 125 million have atherosclerotic cardiovascular diseases (CVD) in the United States, which are known to be the risk factors for the development of heart failure. Thus, the high burden of various diseases creates the risk of pleural effusions among the target population in the United States.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Start-Up in the Malignant Pleural Effusion Market

Key start-up players in the Malignant Pleural Effusion market are-

  • SensoriumLab is a Polish company that offers a user-friendly and non-invasive diagnostic system for assessment of pleural effusion (water on lungs). The device makes it possible to monitor patients remotely, and the monitoring can even be handled by non-professionals.
  • BIORIDIS is a biotech company founded in Bologna, Italy in 2016 that is working to reduce costs, increase productivity and improve technical performance in biomedical R&D and molecular diagnostics. The company’s objective is the development, production and marketing of innovative kits for nucleic acid (DNA, RNA) analysis for biomedical R&D and molecular diagnostics application, especially for small RNAs (e.g. microRNAs).
  • BrainScan Sp. z o. o. is a Polish start-up using artificial intelligence to improve the efficiency of interpretations of Brain CT Scans. Company provides automatic search for similar computed tomography (CT) or magnetic resonance imaging (MRI) scans in large data sets. It searches for medical cases that are similar to a given scan or region of interest.

Market Competition

Key players in the Malignant Pleural Effusion market are Allakos, iCo Therapeutics, Akari Therapeutics, and Santen.

  • In September 2021, BDR Pharma launched BIAPENEM to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections. Biapenem is widely distributed and penetrates well into various tissues (e.g. lung tissue) and body fluids (e.g. sputum, pleural effusion, abdominal cavity fluid).
  • In April 2022, the study titled “IFN-γ Combined with T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites” was registered in ClinicalTrials.gov for Malignant Pleural Effusion.

Report Scope

Report Attribute

Details

Market Value in 2023

US$ 4.5 Billion

Market Value in 2033

US$ 8.06 Billion

Growth Rate

CAGR of 6% from 2023 to 2033

Base Year for Estimation

2022

Historical Data

2018-2022

Forecast Period

2023-2033

Quantitative Units

Revenue in US$ Million and CAGR from 2023-2033

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Treatment
  • End User
  • Diagnosis
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • BENELUX
  • France
  • Germany
  • Italy
  • Nordics
  • Spain
  • U.K
  • Poland
  • Russia
  • India
  • Malaysia
  • Singapore
  • Thailand
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • B. Braun SE
  • Becton, Dickinson and Company
  • Bicakcilar
  • Biometrix
  • Cook Medical
  • Grena
  • Redax
  • Rocket Medical
  • Smith Medical
  • Taiho Pharmaceutical Co. Ltd.

Customization

Available Upon Request

Key Segments Profiled in the Malignant Pleural Effusion Industry Survey

By Diagnosis:

  • Imaging Tests
  • Pleural Thoracentesis
  • Pleural Fluid Cytology
  • Immunohistochemical Tests
  • Pleural Biopsy
  • Thoracoscopy/Pleuroscopy

By End User:

  • Hospitals
  • Ambulatory Clinics
  • Others

By Treatment:

  • Systemic Therapy
  • Therapeutic Thoracentesis
  • Thoracic Drainage and Pleurodesis
  • Indwelling Pleural Catheter

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • MEA

Frequently Asked Questions

From 2017-2022, the Malignant Pleural Effusion market grew at CAGR of 4%.

The global Malignant Pleural Effusion market is expected to grow with a 6% CAGR during 2023-2033.

As of 2033, the Malignant Pleural Effusion market is expected to reach US$ 8.06 Billion

According to the FMI analysis, hospitals account for the largest market share.

North America is expected to possess 45% market share for the Malignant Pleural Effusion market.

The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018-2022 and Forecast, 2023-2033

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Diagnosis

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Diagnosis, 2018-2022

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Diagnosis, 2023-2033

        5.3.1. Imaging Tests

        5.3.2. Pleural Thoracocentesis

        5.3.3. Pleural Fluid Cytology

        5.3.4. Immunohistochemical Tests

        5.3.5. Pleural Biopsy

        5.3.6. Thoracoscopy/Pleuroscopy

    5.4. Y-o-Y Growth Trend Analysis By Diagnosis, 2018-2022

    5.5. Absolute $ Opportunity Analysis By Diagnosis, 2023-2033

6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Treatment

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Treatment, 2018-2022

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment, 2023-2033

        6.3.1. Systemic Therapy

        6.3.2. Therapeutic Thoracentesis

        6.3.3. Thoracic Drainage and Pleurodesis

        6.3.4. Indwelling Pleural Catheter

    6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018-2022

    6.5. Absolute $ Opportunity Analysis By Treatment, 2023-2033

7. Global Market Analysis 2018-2022 and Forecast 2023-2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End User , 2018-2022

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User , 2023-2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Clinics

        7.3.3. Others

    7.4. Y-o-Y Growth Trend Analysis By End User , 2018-2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023-2033

8. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. APAC

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Diagnosis

        9.2.3. By Treatment

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Diagnosis

        9.3.3. By Treatment

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Diagnosis

        10.2.3. By Treatment

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Diagnosis

        10.3.3. By Treatment

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        11.2.1. By Country

            11.2.1.1. Benelux

            11.2.1.2. France

            11.2.1.3. Germany

            11.2.1.4. Italy

            11.2.1.5. Nordic

            11.2.1.6. Spain

            11.2.1.7. U.K.

            11.2.1.8. Rest of Western Europe

        11.2.2. By Diagnosis

        11.2.3. By Treatment

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Diagnosis

        11.3.3. By Treatment

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Rest of Eastern Europe

        12.2.2. By Diagnosis

        12.2.3. By Treatment

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Diagnosis

        12.3.3. By Treatment

        12.3.4. By End User

    12.4. Key Takeaways

13. APAC Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Australia

            13.2.1.6. New Zealand

            13.2.1.7. Rest of APAC

        13.2.2. By Diagnosis

        13.2.3. By Treatment

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Diagnosis

        13.3.3. By Treatment

        13.3.4. By End User

    13.4. Key Takeaways

14. MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Diagnosis

        14.2.3. By Treatment

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Diagnosis

        14.3.3. By Treatment

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Diagnosis

            15.1.2.2. By Treatment

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Diagnosis

            15.2.2.2. By Treatment

            15.2.2.3. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Diagnosis

            15.3.2.2. By Treatment

            15.3.2.3. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Diagnosis

            15.4.2.2. By Treatment

            15.4.2.3. By End User

    15.5. Benelux

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Diagnosis

            15.5.2.2. By Treatment

            15.5.2.3. By End User

    15.6. France

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Diagnosis

            15.6.2.2. By Treatment

            15.6.2.3. By End User

    15.7. Germany

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Diagnosis

            15.7.2.2. By Treatment

            15.7.2.3. By End User

    15.8. Italy

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Diagnosis

            15.8.2.2. By Treatment

            15.8.2.3. By End User

    15.9. Nordic

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Diagnosis

            15.9.2.2. By Treatment

            15.9.2.3. By End User

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Diagnosis

            15.10.2.2. By Treatment

            15.10.2.3. By End User

    15.11. U.K.

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Diagnosis

            15.11.2.2. By Treatment

            15.11.2.3. By End User

    15.12. Poland

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Diagnosis

            15.12.2.2. By Treatment

            15.12.2.3. By End User

    15.13. Russia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Diagnosis

            15.13.2.2. By Treatment

            15.13.2.3. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Diagnosis

            15.14.2.2. By Treatment

            15.14.2.3. By End User

    15.15. Malaysia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Diagnosis

            15.15.2.2. By Treatment

            15.15.2.3. By End User

    15.16. Singapore

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Diagnosis

            15.16.2.2. By Treatment

            15.16.2.3. By End User

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Diagnosis

            15.17.2.2. By Treatment

            15.17.2.3. By End User

    15.18. Australia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Diagnosis

            15.18.2.2. By Treatment

            15.18.2.3. By End User

    15.19. New Zealand

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Diagnosis

            15.19.2.2. By Treatment

            15.19.2.3. By End User

    15.20. GCC Countries

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Diagnosis

            15.20.2.2. By Treatment

            15.20.2.3. By End User

    15.21. South Africa

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Diagnosis

            15.21.2.2. By Treatment

            15.21.2.3. By End User

    15.22. Israel

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Diagnosis

            15.22.2.2. By Treatment

            15.22.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Diagnosis

        16.3.3. By Treatment

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. B. Braun SE

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Becton, Dickinson and Company

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Bicakcilar

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Biometrix

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Cook Medical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Grena

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Redax

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Rocket Medical

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Smith Medical

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Taiho Pharmaceutical Co., Ltd

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2018-2033

Table 2: Global Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 3: Global Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 4: Global Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 6: North America Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 7: North America Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 8: North America Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 10: Latin America Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 11: Latin America Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 12: Latin America Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 13: Western Europe Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 14: Western Europe Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 15: Western Europe Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 16: Western Europe Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 17: Eastern Europe Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 18: Eastern Europe Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 19: Eastern Europe Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 20: Eastern Europe Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 21: APAC Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 22: APAC Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 23: APAC Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 24: APAC Market Value (US$ Mn) Forecast by End User , 2018-2033

Table 25: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 26: MEA Market Value (US$ Mn) Forecast by Diagnosis, 2018-2033

Table 27: MEA Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 28: MEA Market Value (US$ Mn) Forecast by End User , 2018-2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 2: Global Market Value (US$ Mn) by Treatment, 2023-2033

Figure 3: Global Market Value (US$ Mn) by End User , 2023-2033

Figure 4: Global Market Value (US$ Mn) by Region, 2023-2033

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2018-2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033

Figure 8: Global Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 11: Global Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 14: Global Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 17: Global Market Attractiveness by Diagnosis, 2023-2033

Figure 18: Global Market Attractiveness by Treatment, 2023-2033

Figure 19: Global Market Attractiveness by End User , 2023-2033

Figure 20: Global Market Attractiveness by Region, 2023-2033

Figure 21: North America Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 22: North America Market Value (US$ Mn) by Treatment, 2023-2033

Figure 23: North America Market Value (US$ Mn) by End User , 2023-2033

Figure 24: North America Market Value (US$ Mn) by Country, 2023-2033

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 28: North America Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 31: North America Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 34: North America Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 37: North America Market Attractiveness by Diagnosis, 2023-2033

Figure 38: North America Market Attractiveness by Treatment, 2023-2033

Figure 39: North America Market Attractiveness by End User , 2023-2033

Figure 40: North America Market Attractiveness by Country, 2023-2033

Figure 41: Latin America Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 42: Latin America Market Value (US$ Mn) by Treatment, 2023-2033

Figure 43: Latin America Market Value (US$ Mn) by End User , 2023-2033

Figure 44: Latin America Market Value (US$ Mn) by Country, 2023-2033

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 48: Latin America Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 51: Latin America Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 54: Latin America Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 57: Latin America Market Attractiveness by Diagnosis, 2023-2033

Figure 58: Latin America Market Attractiveness by Treatment, 2023-2033

Figure 59: Latin America Market Attractiveness by End User , 2023-2033

Figure 60: Latin America Market Attractiveness by Country, 2023-2033

Figure 61: Western Europe Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 62: Western Europe Market Value (US$ Mn) by Treatment, 2023-2033

Figure 63: Western Europe Market Value (US$ Mn) by End User , 2023-2033

Figure 64: Western Europe Market Value (US$ Mn) by Country, 2023-2033

Figure 65: Western Europe Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 68: Western Europe Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 71: Western Europe Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 74: Western Europe Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 77: Western Europe Market Attractiveness by Diagnosis, 2023-2033

Figure 78: Western Europe Market Attractiveness by Treatment, 2023-2033

Figure 79: Western Europe Market Attractiveness by End User , 2023-2033

Figure 80: Western Europe Market Attractiveness by Country, 2023-2033

Figure 81: Eastern Europe Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 82: Eastern Europe Market Value (US$ Mn) by Treatment, 2023-2033

Figure 83: Eastern Europe Market Value (US$ Mn) by End User , 2023-2033

Figure 84: Eastern Europe Market Value (US$ Mn) by Country, 2023-2033

Figure 85: Eastern Europe Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 88: Eastern Europe Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 91: Eastern Europe Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 94: Eastern Europe Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 97: Eastern Europe Market Attractiveness by Diagnosis, 2023-2033

Figure 98: Eastern Europe Market Attractiveness by Treatment, 2023-2033

Figure 99: Eastern Europe Market Attractiveness by End User , 2023-2033

Figure 100: Eastern Europe Market Attractiveness by Country, 2023-2033

Figure 101: APAC Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 102: APAC Market Value (US$ Mn) by Treatment, 2023-2033

Figure 103: APAC Market Value (US$ Mn) by End User , 2023-2033

Figure 104: APAC Market Value (US$ Mn) by Country, 2023-2033

Figure 105: APAC Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 106: APAC Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 107: APAC Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 108: APAC Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 109: APAC Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 110: APAC Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 111: APAC Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 112: APAC Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 113: APAC Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 114: APAC Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 115: APAC Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 116: APAC Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 117: APAC Market Attractiveness by Diagnosis, 2023-2033

Figure 118: APAC Market Attractiveness by Treatment, 2023-2033

Figure 119: APAC Market Attractiveness by End User , 2023-2033

Figure 120: APAC Market Attractiveness by Country, 2023-2033

Figure 121: MEA Market Value (US$ Mn) by Diagnosis, 2023-2033

Figure 122: MEA Market Value (US$ Mn) by Treatment, 2023-2033

Figure 123: MEA Market Value (US$ Mn) by End User , 2023-2033

Figure 124: MEA Market Value (US$ Mn) by Country, 2023-2033

Figure 125: MEA Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 126: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 127: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 128: MEA Market Value (US$ Mn) Analysis by Diagnosis, 2018-2033

Figure 129: MEA Market Value Share (%) and BPS Analysis by Diagnosis, 2023-2033

Figure 130: MEA Market Y-o-Y Growth (%) Projections by Diagnosis, 2023-2033

Figure 131: MEA Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 132: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 133: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 134: MEA Market Value (US$ Mn) Analysis by End User , 2018-2033

Figure 135: MEA Market Value Share (%) and BPS Analysis by End User , 2023-2033

Figure 136: MEA Market Y-o-Y Growth (%) Projections by End User , 2023-2033

Figure 137: MEA Market Attractiveness by Diagnosis, 2023-2033

Figure 138: MEA Market Attractiveness by Treatment, 2023-2033

Figure 139: MEA Market Attractiveness by End User , 2023-2033

Figure 140: MEA Market Attractiveness by Country, 2023-2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Catheter Systems Market

Published : July 2019

Healthcare

Pleural Cavity Drainage Market

Published : April 2018

Healthcare

Pleural Effusions Treatment Market

Published : April 2017

Healthcare

Malignant Ascites Market

Published : June 2016

Google translate

Malignant Pleural Effusion Market